Ceridian HCM (CDAY) Misses Q4 EPS by 11c

Ceridian HCM (NYSE: CDAY) reported Q4 EPS of ($0.06), $0.11 worse than the analyst estimate of $0.05. Revenue for the quarter came in at $282.1 million versus the consensus estimate of $347.32 million.

GUIDANCE:

Ceridian HCM sees Q1 2022 revenue of $1.19-1.22 billion, versus the consensus of $1.29 billion.

For earnings history and earnings-related data on Ceridian HCM (CDAY) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c